Evaluating Safety and Efficacy In Hepatitis C Patients After PegIntron Pen Treatment (Study P04896)
Status:
Terminated
Trial end date:
2007-10-01
Target enrollment:
Participant gender:
Summary
This is a non-interventional study designed to evaluate the efficacy and safety of
combination study drugs in the treatment of participants diagnosed with Chronic Hepatitis C
(CHC). CHC participants with confirmed positive hepatitis-C virus (HCV) RNA in plasma, and
who have not been previously treated with the Pegylated interferon (PegIntron) Pen, were
enrolled into study.